← All Torts

Zantac

19 signals found · Updated in real-time

REGULATORY Mar 3, 2026
SRES 615: "A resolution celebrating Black History Month.". Latest action (2026-02-25): Submitted in the Senate, consider
ed, and agreed to without amendment and with a preamble by Unanimous Consent.....
View Source →
REGULATORY Mar 3, 2026
HR 7396: "Native American Entrepreneurial Opportunity Act". Latest action (2026-02-17): Placed on the Union Calendar, Ca
lendar No. 424.....
View Source →
REGULATORY Mar 3, 2026
S 233: "Restoring Confidence in the World Anti-Doping Agency Act of 2025". Latest action (2026-02-23): Placed on Senate
Legislative Calendar under General Orders. Calendar No. 340.....
View Source →
REGULATORY Mar 3, 2026
S 233: "Restoring Confidence in the World Anti-Doping Agency Act of 2025". Latest action (2026-02-23): Placed on Senate
Legislative Calendar under General Orders. Calendar No. 340.....
View Source →
REGULATORY Mar 2, 2026
S 3832: "Small Business Workforce Pipeline Act of 2026". Latest action (2026-02-11): Read twice and referred to the Comm
ittee on Small Business and Entrepreneurship.....
View Source →
REGULATORY Mar 2, 2026
S 3853: "End the Vaccine Carveout Act". Latest action (2026-02-11): Read twice and referred to the Committee on Health,
Education, Labor, and Pensions.....
View Source →
REGULATORY Mar 2, 2026
S 3889: "American Lending Fairness Act of 2026". Latest action (2026-02-12): Read twice and referred to the Committee on
Banking, Housing, and Urban Affairs.....
View Source →
LITIGATION Mar 2, 2026
On or before January 16, 2026, parties in the Zantac litigation will file briefs on grouping cases in sets of five or tr
ying them individually....
View Source →
LITIGATION Mar 2, 2026
GSK announced on October 9, 2024, settlement agreements resolving 93% (approximately 80,000 cases) of U.S. state court Z
antac litigation....
View Source →
LITIGATION Mar 2, 2026
Oral arguments in the Zantac MDL appeal were held on October 6, 2025, challenging the dismissal of federal cases over un
reliable expert testimony on NDMA-cancer link....
View Source →
REGULATORY Mar 2, 2026
ZANTAC: 560 adverse events reported in last 90 days (-74% vs prior period). Prior 90 days: 2196.
View Source →
REGULATORY Mar 2, 2026
RANITIDINE: 121 adverse events reported in last 90 days (-64% vs prior period). Prior 90 days: 337.
View Source →
SCIENTIFIC Mar 1, 2026
New study (2026): "Association Between Long-term Use of H(2) Receptor Antagonists and Prostate Cancer Risk: A Case-Contr
ol Study in Taiwan." by Wang SF, Liu YC, Nguyen PA. 5 total studies found in last 90 days for "ranitidine cancer"....
View Source →
SCIENTIFIC Mar 1, 2026
New study (2026 Jan 21): "Esophageal Acid Suppression Unmasks Latent Esophageal Acid-Symptom Phenotypes in GERD." by Gar
dner JD, Triadafilopoulos G. 5 total studies found in last 90 days for "ranitidine cancer"....
View Source →
SCIENTIFIC Mar 1, 2026
New study (2025 Dec): "Crystal defects cause nitrosamine formation in ranitidine under accelerated storage conditions."
by Xu J, Huls NJ, Jannasch AS. 1 total studies found in last 90 days for "ranitidine NDMA"....
View Source →
REGULATORY Mar 1, 2026
SRES 619: "A resolution designating February 16, 2026, as "National Elizabeth Peratrovich Day".". Latest action (2026-02
-26): Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S716; text: CR S711)....
View Source →
LITIGATION Mar 1, 2026
1 new federal court filings mentioning "ranitidine" in the last 30 days.
View Source →
REGULATORY Mar 1, 2026
S 3886: "Nurses Belong in Nursing Homes Act". Latest action (2026-02-12): Read twice and referred to the Committee on Fi
nance.....
View Source →
LITIGATION Mar 1, 2026
New filing: State of Connecticut v. Novartis AG (filed 2026-02-02). Court: District Court, D. Connecticut.
View Source →

🔒 Full Causation Analysis Available

Get PRR scores, PubMed literature analysis, Bradford Hill scoring,
and weekly alert digests for Zantac litigation.

Access Intelligence →